Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 120


Cardiometabolic risks vary by weight status in pediatric kidney and liver transplant recipients: A cross-sectional, single-center study in the USA.

He S, Le NA, Frediani JK, Winterberg PD, Jin R, Liverman R, Hernandez A, Cleeton RL, Vos MB.

Pediatr Transplant. 2017 Jul 17. doi: 10.1111/petr.12984. [Epub ahead of print]


Baroreflex dysfunction and augmented sympathetic nerve responses during mental stress in veterans with post-traumatic stress disorder.

Park J, Marvar PJ, Liao P, Kankam ML, Norrholm SD, Downey RM, McCullough SA, Le NA, Rothbaum BO.

J Physiol. 2017 Jul 15;595(14):4893-4908. doi: 10.1113/JP274269. Epub 2017 Jun 14.


Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.

Thongtang N, Diffenderfer MR, Ooi EMM, Barrett PHR, Turner SM, Le NA, Brown WV, Schaefer EJ.

J Lipid Res. 2017 Jul;58(7):1315-1324. doi: 10.1194/jlr.M073882. Epub 2017 Apr 9.


Postprandial Clearance of Oxidized Low-Density Lipoprotein in Patients with Stroke Due to Atherosclerosis.

Al Kasab S, Cassarly C, Le NA, Martin R, Brinley J, Chimowitz MI, Turan TN.

J Stroke Cerebrovasc Dis. 2017 Mar;26(3):488-493. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.006. Epub 2017 Jan 6.


Relationship between risk factor control and vascular events in the SAMMPRIS trial.

Turan TN, Nizam A, Lynn MJ, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Harrell J, Derdeyn CP, Fiorella D, Janis LS, Lane B, Montgomery J, Chimowitz MI.

Neurology. 2017 Jan 24;88(4):379-385. doi: 10.1212/WNL.0000000000003534. Epub 2016 Dec 21.


Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease.

Jin R, Krasinskas A, Le NA, Konomi JV, Holzberg J, Romero R, Vos MB.

Pediatr Obes. 2016 Oct 20. doi: 10.1111/ijpo.12183. [Epub ahead of print]


The impact of moderate distance recreational running and ageing on cardiac physiology.

Kim JH, Ko YA, Hedley J, MacNamara J, Awad M, Taylor W, Healy S, Aida H, Le NA, Wilson PW, White M, Sperling LS, Wilson JS Jr, Baggish AL.

Heart. 2017 Feb;103(3):219-226. doi: 10.1136/heartjnl-2016-310059. Epub 2016 Aug 16.


Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight.

Holzberg JR, Jin R, Le NA, Ziegler TR, Brunt EM, McClain CJ, Konomi JV, Arteel GE, Vos MB.

J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):819-23. doi: 10.1097/MPG.0000000000001096.


Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents.

Jin R, Le NA, Cleeton R, Sun X, Cruz Muños J, Otvos J, Vos MB.

Lipids Health Dis. 2015 May 1;14:39. doi: 10.1186/s12944-015-0038-x.


Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner.

Le NA, Diffenderfer MR, Thongtang N, Ooi EM, Barrett PH, Horvath KV, Dolnikowski GG, Asztalos BF, Schaefer EJ, Brown WV.

Lipids. 2015 May;50(5):447-58. doi: 10.1007/s11745-015-4005-0. Epub 2015 Mar 26.


Underappreciated opportunities for high-density lipoprotein particles in risk stratification and potential targets of therapy.

Rosenson RS, Davidson MH, Le NA, Burkle J, Pourfarzib R.

Cardiovasc Drugs Ther. 2015 Feb;29(1):41-50. doi: 10.1007/s10557-014-6567-0. Review.


Lipoprotein-associated oxidative stress: a new twist to the postprandial hypothesis.

Le NA.

Int J Mol Sci. 2014 Dec 26;16(1):401-19. doi: 10.3390/ijms16010401. Review.


Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.

Eapen DJ, Manocha P, Ghasemzadeh N, Patel RS, Al Kassem H, Hammadah M, Veledar E, Le NA, Pielak T, Thorball CW, Velegraki A, Kremastinos DT, Lerakis S, Sperling L, Quyyumi AA.

J Am Heart Assoc. 2014 Oct 23;3(5):e001118. doi: 10.1161/JAHA.114.001118. Erratum in: J Am Heart Assoc. 2015 Jan;4(1):e000563. Ghasemzedah, Nima [Corrected to Ghasemzadeh, Nima].


Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD.

Jin R, Welsh JA, Le NA, Holzberg J, Sharma P, Martin DR, Vos MB.

Nutrients. 2014 Aug 8;6(8):3187-201. doi: 10.3390/nu6083187.


Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes.

Le NA, Katsuyama M, Demura M, Tanii H, Katsuyama H, Saijoh K.

Environ Health Prev Med. 2014 Jul;19(4):307-13. doi: 10.1007/s12199-014-0393-7. Epub 2014 Jun 4.


Glial cell line-derived neurotrophic factor protects against high-fat diet-induced obesity.

Mwangi SM, Nezami BG, Obukwelu B, Anitha M, Marri S, Fu P, Epperson MF, Le NA, Shanmugam M, Sitaraman SV, Tseng YH, Anania FA, Srinivasan S.

Am J Physiol Gastrointest Liver Physiol. 2014 Mar;306(6):G515-25. doi: 10.1152/ajpgi.00364.2013. Epub 2014 Jan 23.


Effect of ABT-335 (fenofibric acid) on meal-induced oxidative stress in patients with metabolic syndrome.

Le NA, Farkas-Epperson M, Sweeney ME, Wilson PW, Virgil Brown W.

Atherosclerosis. 2013 Dec;231(2):268-73. doi: 10.1016/j.atherosclerosis.2013.09.022. Epub 2013 Oct 7.


Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.

Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.

Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.


Changes in lipoprotein particle number with ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidemic patients.

Le NA, Jin R, Tomassini JE, Tershakovec AM, Neff DR, Wilson PW.

J Am Heart Assoc. 2013 Aug 7;2(4):e000037. doi: 10.1161/JAHA.113.000037.

Supplemental Content

Loading ...
Support Center